- NOK4.22bn
- NOK4.06bn
- NOK699.77m
Brief: Medistim Posts Q1 EBIT of NOK 33.5 Million
Brief: Medistim Opens Direct Sales Office In China
Brief: Medistim Q4 EBIT Up At NOK 36.5 Mln
Brief: Medistim Q4 EBIT at NOK 36.5 Million
Brief: Medistim Transfers 12,000 Shares To Co's CEO Kari E. Krogstad
Brief: Medistim Q3 EBIT Rises To NOK 34.0 mln
Brief: Medistim Q2 EBIT Falls To NOK 37.4 Mln
Brief: Medistim joins GE Vingmed Ultrasound and Sensocure in joint project
Brief: Medistim Q3 EBIT up at NOK 19.4 mln
Brief: Medistim Q2 EBIT falls to NOK 13.6 million
Brief: Medistim receives clearance in China for sale of MiraQ
Brief: Medistim Q1 EBIT up at NOK 16.0 million
Brief: Medistim Q4 EBIT decreases to NOK 9.7 mln
Brief: Medistim establishes own subsidiary in Spain
Brief: Medistim establishes direct sales operations in Spain
Brief: Medistim Q3 EBIT rises to NOK 15.9 million
Brief: Medistim Q2 EBIT up at NOK 17.1 million
Brief: Medistim's technology has achieved reimbursement in Japan
Brief: Medistim Q1 operating profit NOK 13.5 mln, up 37.2%